Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Muhammed A, Thomas C, Kalaiselvan V, Undela K
With Indias rapidly growing diabetic population and rising awareness of obesity, GLP-1 therapies present a significant growth opportunity.Eris has established a strong presence in diabetology through deep engagement with specialists across India
They may need to refer you to a specialist weight management service for weight loss
Schjoedt KJ, Rossing K, Juhl TR et al (2005) Beneficial impact of spironolactone in diabetic nephropathy
US$ 29.62
US$ 20.39
US$ 25.80
US$ 22.83
US$ 21.45
US$ 20.32
US$ 22.66
